AbbVie Inc., a biopharmaceutical company incorporated in Delaware, has filed a Registration Statement on Form S-8 with the United States Securities and Exchange Commission (SEC) on November 4, 2024. The purpose of this filing is to register additional shares of common stock that may be offered or sold under the AbbVie Savings Program. This program is designed for employee participation and the registration also covers an indeterminate amount of plan interests. The filing is in accordance with General Instruction E to Form S-8, which pertains to the registration of additional securities. AbbVie Inc. has referenced its prior Registration Statement from December 19, 2012, and has included exhibits detailing its corporate governance documents and the consent of Ernst & Young LLP. The company has confirmed compliance with IRS regulations for the AbbVie Savings Program to qualify under Section 401 of the U.S. Internal Revenue Code. The Registration Statement has been signed by key executives including the CEO, CFO, and other directors of AbbVie Inc.

AbbVie Inc., a biopharmaceutical company incorporated in Delaware, has filed a Registration Statement on Form S-8 with the United States Securities and Exchange Commission (SEC) on November 4, 2024. The purpose of this filing is to register additional shares of common stock that may be offered or sold under the AbbVie Savings Program. This program is designed for employee participation and the registration also covers an indeterminate amount of plan interests. The filing is in accordance with General Instruction E to Form S-8, which pertains to the registration of additional securities. AbbVie Inc. has referenced its prior Registration Statement from December 19, 2012, and has included exhibits detailing its corporate governance documents and the consent of Ernst & Young LLP. The company has confirmed compliance with IRS regulations for the AbbVie Savings Program to qualify under Section 401 of the U.S. Internal Revenue Code. The Registration Statement has been signed by key executives including the CEO, CFO, and other directors of AbbVie Inc.